CN107748256B - 一种循环肿瘤细胞的液体活检检测方法 - Google Patents
一种循环肿瘤细胞的液体活检检测方法 Download PDFInfo
- Publication number
- CN107748256B CN107748256B CN201710943050.7A CN201710943050A CN107748256B CN 107748256 B CN107748256 B CN 107748256B CN 201710943050 A CN201710943050 A CN 201710943050A CN 107748256 B CN107748256 B CN 107748256B
- Authority
- CN
- China
- Prior art keywords
- fluorescence
- hybridization
- cell
- signal
- situ hybridization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 title claims abstract description 80
- 238000001514 detection method Methods 0.000 title claims abstract description 46
- 238000011528 liquid biopsy Methods 0.000 title abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 100
- 238000000338 in vitro Methods 0.000 claims abstract description 15
- 210000004027 cell Anatomy 0.000 claims description 127
- 238000009396 hybridization Methods 0.000 claims description 117
- 238000007901 in situ hybridization Methods 0.000 claims description 48
- 210000004881 tumor cell Anatomy 0.000 claims description 36
- 210000000265 leukocyte Anatomy 0.000 claims description 27
- 230000011218 segmentation Effects 0.000 claims description 19
- 239000011324 bead Substances 0.000 claims description 16
- 210000003743 erythrocyte Anatomy 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- 239000000523 sample Substances 0.000 claims description 15
- 230000009089 cytolysis Effects 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 230000002708 enhancing effect Effects 0.000 claims description 7
- 229940051173 recombinant immunotoxin Drugs 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 230000009466 transformation Effects 0.000 claims description 7
- 230000001413 cellular effect Effects 0.000 claims description 6
- 230000000877 morphologic effect Effects 0.000 claims description 6
- 239000003298 DNA probe Substances 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 108020003215 DNA Probes Proteins 0.000 claims description 3
- 229940051026 immunotoxin Drugs 0.000 claims description 3
- 230000002637 immunotoxin Effects 0.000 claims description 3
- 239000002596 immunotoxin Substances 0.000 claims description 3
- 231100000608 immunotoxin Toxicity 0.000 claims description 3
- 230000003053 immunization Effects 0.000 claims description 2
- 238000002649 immunization Methods 0.000 claims description 2
- 238000013507 mapping Methods 0.000 claims description 2
- 239000006285 cell suspension Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 31
- 238000012544 monitoring process Methods 0.000 abstract description 14
- 238000011282 treatment Methods 0.000 abstract description 12
- 238000011161 development Methods 0.000 abstract description 6
- 238000012136 culture method Methods 0.000 abstract description 5
- 238000011156 evaluation Methods 0.000 abstract description 5
- 238000004393 prognosis Methods 0.000 abstract description 4
- 238000003320 cell separation method Methods 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- 238000005516 engineering process Methods 0.000 description 19
- 229940079593 drug Drugs 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 238000011160 research Methods 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000000684 flow cytometry Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 210000000601 blood cell Anatomy 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000003125 immunofluorescent labeling Methods 0.000 description 4
- 102000016607 Diphtheria Toxin Human genes 0.000 description 3
- 108010053187 Diphtheria Toxin Proteins 0.000 description 3
- 101150029707 ERBB2 gene Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940044683 chemotherapy drug Drugs 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000012137 double-staining Methods 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 101150023956 ALK gene Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102000028180 Glycophorins Human genes 0.000 description 2
- 108091005250 Glycophorins Proteins 0.000 description 2
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
- 108010013709 Leukocyte Common Antigens Proteins 0.000 description 2
- 102000017095 Leukocyte Common Antigens Human genes 0.000 description 2
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 238000011532 immunohistochemical staining Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- 238000012604 3D cell culture Methods 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 210000003040 circulating cell Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000018732 detection of tumor cell Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000011337 individualized treatment Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000012739 integrated shape imaging system Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000003064 k means clustering Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011155 quantitative monitoring Methods 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003239 susceptibility assay Methods 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710943050.7A CN107748256B (zh) | 2017-10-11 | 2017-10-11 | 一种循环肿瘤细胞的液体活检检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710943050.7A CN107748256B (zh) | 2017-10-11 | 2017-10-11 | 一种循环肿瘤细胞的液体活检检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107748256A CN107748256A (zh) | 2018-03-02 |
CN107748256B true CN107748256B (zh) | 2020-04-14 |
Family
ID=61255299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710943050.7A Active CN107748256B (zh) | 2017-10-11 | 2017-10-11 | 一种循环肿瘤细胞的液体活检检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107748256B (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109003255B (zh) * | 2018-06-11 | 2020-11-10 | 武汉海星通技术股份有限公司 | 荧光原位杂交图像的细胞核分割方法及系统 |
CN111321076A (zh) * | 2018-12-13 | 2020-06-23 | 举康(上海)生物科技有限公司 | 一体化循环肿瘤细胞分离测序系统 |
CN109781988A (zh) * | 2019-02-28 | 2019-05-21 | 贵州省人民医院 | 采用her2基因扩增法检测乳腺癌循环肿瘤细胞的特异性方法 |
CN110136118A (zh) * | 2019-05-15 | 2019-08-16 | 林伟阳 | 一种基于轮廓提取的细胞计数方法 |
CN111429440B (zh) * | 2020-03-31 | 2023-04-28 | 上海杏脉信息科技有限公司 | 显微病理图像细胞充足检测方法、系统、设备、装置及介质 |
CN113782095B (zh) * | 2020-06-10 | 2023-11-28 | 香港城市大学深圳研究院 | 一种高通量实时检测细胞状态的方法 |
CN112432948A (zh) * | 2020-12-03 | 2021-03-02 | 中国人民解放军陆军军医大学第二附属医院 | 一种外周血细胞形态学自动检测方法 |
IT202100023900A1 (it) | 2021-09-16 | 2023-03-16 | Univ Degli Studi Di Perugia | Metodo per la diagnosi e la prognosi di tumori |
CN116188463A (zh) * | 2023-04-24 | 2023-05-30 | 中国科学院长春光学精密机械与物理研究所 | Fish图像信号自动检测分析方法、装置、设备以及介质 |
CN116189179B (zh) * | 2023-04-28 | 2023-08-15 | 北京航空航天大学杭州创新研究院 | 循环肿瘤细胞扫描分析设备 |
CN116309543B (zh) * | 2023-05-10 | 2023-08-11 | 北京航空航天大学杭州创新研究院 | 基于图像的循环肿瘤细胞检测设备 |
CN116363123B (zh) * | 2023-05-23 | 2023-12-22 | 杭州华得森生物技术有限公司 | 对循环肿瘤细胞检测的荧光显微成像系统及其方法 |
CN116287138B (zh) * | 2023-05-23 | 2023-08-11 | 杭州华得森生物技术有限公司 | 基于fish的细胞检测系统及其方法 |
CN116434226B (zh) * | 2023-06-08 | 2024-03-19 | 杭州华得森生物技术有限公司 | 循环肿瘤细胞分析仪 |
CN116485801B (zh) * | 2023-06-26 | 2023-09-12 | 山东兰通机电有限公司 | 基于计算机视觉的胶管质量在线检测方法及系统 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1218411A (zh) * | 1996-03-13 | 1999-06-02 | 奥伊斯坦·福德斯塔德 | 杀死不想要的靶细胞的方法 |
CN103031276A (zh) * | 2012-09-17 | 2013-04-10 | 孙小娟 | 一种获取循环肿瘤单细胞的方法 |
CN104403923A (zh) * | 2014-11-11 | 2015-03-11 | 南京卡迪奥密生物技术有限公司 | 三维组织器官培养模型及其高通量自动化立体图像分析平台及其应用 |
CN106596941A (zh) * | 2016-12-21 | 2017-04-26 | 上海市质子重离子医院有限公司 | 一种检测前列腺癌循环肿瘤细胞的检测方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU646635B2 (en) * | 1989-03-07 | 1994-03-03 | Syngene, Inc. | In-situ hybridization in suspension for detection or separation of cells |
US8131053B2 (en) * | 1999-01-25 | 2012-03-06 | Amnis Corporation | Detection of circulating tumor cells using imaging flow cytometry |
US20030104439A1 (en) * | 2001-11-30 | 2003-06-05 | Finch Rosalynde J. | Methods of identifying cellular target molecules |
WO2008008515A2 (en) * | 2006-07-14 | 2008-01-17 | Aviva Biosciences Corporation | Methods and compositions for detecting rare cells from a biological sample |
CN107058456A (zh) * | 2017-06-02 | 2017-08-18 | 四川精准医学检验有限责任公司 | 一种循环肿瘤细胞3d药敏试验方法 |
-
2017
- 2017-10-11 CN CN201710943050.7A patent/CN107748256B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1218411A (zh) * | 1996-03-13 | 1999-06-02 | 奥伊斯坦·福德斯塔德 | 杀死不想要的靶细胞的方法 |
CN103031276A (zh) * | 2012-09-17 | 2013-04-10 | 孙小娟 | 一种获取循环肿瘤单细胞的方法 |
CN104403923A (zh) * | 2014-11-11 | 2015-03-11 | 南京卡迪奥密生物技术有限公司 | 三维组织器官培养模型及其高通量自动化立体图像分析平台及其应用 |
CN106596941A (zh) * | 2016-12-21 | 2017-04-26 | 上海市质子重离子医院有限公司 | 一种检测前列腺癌循环肿瘤细胞的检测方法 |
Non-Patent Citations (1)
Title |
---|
Fluorescent In Situ Hybridization In Suspension by Imaging Flow Cytometry;Orla Maguire et al;《Methods Mol Biol.》;20161231;第1389卷;摘要,第4页第3.2节,第6页第3.3节,图3 * |
Also Published As
Publication number | Publication date |
---|---|
CN107748256A (zh) | 2018-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107748256B (zh) | 一种循环肿瘤细胞的液体活检检测方法 | |
US10657643B2 (en) | Medical image analysis for identifying biomarker-positive tumor cells | |
He et al. | A new method for CTC images recognition based on machine learning | |
CN104094116B (zh) | 在哺乳动物个体中检测5t4阳性循环肿瘤细胞的方法和诊断5t4阳性癌症的方法 | |
CN104007257A (zh) | 一种检测非体液性稀有有核细胞的方法和试剂盒 | |
WO2012041333A1 (en) | Automated imaging, detection and grading of objects in cytological samples | |
Uslu et al. | Automated quantification of immunomagnetic beads and leukemia cells from optical microscope images | |
Faivdullah et al. | Leukemia detection from blood smears | |
CN105684989A (zh) | 一种肝癌pdx标准化模型库 | |
JP2011186750A (ja) | 測定対象分子の定量的解析方法及び装置 | |
WO2006036735A2 (en) | Method for detecting and quantitating multiple subcellular components | |
US20180040120A1 (en) | Methods for quantitative assessment of mononuclear cells in muscle tissue sections | |
CN116757998A (zh) | 基于ai的ctc细胞和ctc样细胞的筛查方法及装置 | |
CN105018585B (zh) | 一种预测甲状腺肿瘤良恶性的试剂盒 | |
CN114022472B (zh) | 一种肿瘤浸润淋巴细胞分析方法、装置和存储介质 | |
Kuo et al. | Automated assessment in HER-2/neu immunohistochemical expression of breast cancer | |
CN111596053B (zh) | Tpn分子在制备循环肿瘤细胞检测试剂中的用途及检测试剂和试剂盒 | |
Sagonas et al. | FISH image analysis using a modified radial basis function network | |
Kachouie et al. | Constrained watershed method to infer morphology of mammalian cells in microscopic images | |
US11908130B2 (en) | Apparatuses and methods for digital pathology | |
Radziuviene et al. | Research Article Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue | |
Nagy et al. | Spatial analytics of the tumor microenvironment on double stained immunohistochemistry images using deep learning | |
Dzulkifli et al. | A Review: Recent Approaches on Improving the Accuracy in Determining the Tumor and Cancer Grading in Histopathological Images Based on Scoring Ki67 Expression. | |
Sirinukunwattana et al. | Quantifying chromosomal copy number alterations in breast ductal carcinoma in situ: A deep learning based approach | |
Restif | Towards safer, faster prenatal genetic tests: Novel unsupervised, automatic and robust methods of segmentation of nuclei and probes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180921 Address after: 230601 A302, science and engineering building, Xinyuan campus, Anhui University, 111, Kowloon Road, Hefei, Anhui Applicant after: Liu Jianfei Address before: 201800 J698, 1 building 2222, ring road, Juyuan New District, Jiading District, Shanghai. Applicant before: Shanghai Medical Network Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190110 Address after: 361006 Torch Industrial Development Zone, Huli District, Xiamen City, Fujian Province Applicant after: Xiamen Miaoke Code Biotechnology Co., Ltd. Address before: 230601 A302, science and engineering building, Xinyuan campus, Anhui University, 111, Kowloon Road, Hefei, Anhui Applicant before: Liu Jianfei |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |